Cargando…

New Challenges in Heart Failure with Reduced Ejection Fraction: Managing Worsening Events

Patients with an established diagnosis of heart failure (HF) with reduced ejection fraction (HFrEF) are prone to experience episodes of worsening symptoms and signs despite continued therapy, termed “worsening heart failure” (WHF). Despite guideline-directed medical therapy, worsening of chronic hea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lavalle, Carlo, Di Lullo, Luca, Jabbour, Jean Pierre, Palombi, Marta, Trivigno, Sara, Mariani, Marco Valerio, Summaria, Francesco, Severino, Paolo, Badagliacca, Roberto, Miraldi, Fabio, Bellasi, Antonio, Vizza, Carmine Dario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672118/ https://www.ncbi.nlm.nih.gov/pubmed/38002571 http://dx.doi.org/10.3390/jcm12226956

Ejemplares similares

Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial Fibrillation
por: Mariani, Marco Valerio, et al.
Publicado: (2022)

Five Years of Direct Oral Anticoagulants Use in Italy: Adverse Drug Reactions from the Italian National Pharmacovigilance Network
por: Lavalle, Carlo, et al.
Publicado: (2022)

Protection against Ischemic Heart Disease: A Joint Role for eNOS and the K(ATP) Channel
por: Severino, Paolo, et al.
Publicado: (2023)

Finerenone: Questions and Answers—The Four Fundamental Arguments on the New-Born Promising Non-Steroidal Mineralocorticoid Receptor Antagonist
por: Di Lullo, Luca, et al.
Publicado: (2023)

Telemedicine: an Effective and Low-Cost Lesson From the COVID-19 Pandemic for the Management of Heart Failure Patients
por: Severino, Paolo, et al.
Publicado: (2023)

Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
por: Caputo, Annalisa, et al.
Publicado: (2023)

The Role of MicroRNA in the Myocarditis: a Small Actor for a Great Role
por: Chimenti, Cristina, et al.
Publicado: (2023)

Impact of COVID-19 Pandemic on Cardiac Electronic Device Management and Role of Remote Monitoring
por: Magnocavallo, Michele, et al.
Publicado: (2022)

The Feasibility, Effectiveness and Acceptance of Virtual Visits as Compared to In-Person Visits among Clinical Electrophysiology Patients during the COVID-19 Pandemic
por: Mariani, Marco Valerio, et al.
Publicado: (2023)

Comment on Topyła-Putowska et al. Echocardiography in Pulmonary Arterial Hypertension: Comprehensive Evaluation and Technical Considerations. J. Clin. Med. 2021, 10, 3229
por: Manzi, Giovanna, et al.
Publicado: (2022)

A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy
por: Chimenti, Cristina, et al.
Publicado: (2021)

Structural and myocardial dysfunction in heart failure beyond ejection fraction
por: Severino, Paolo, et al.
Publicado: (2019)

Flecainide in Ventricular Arrhythmias: From Old Myths to New Perspectives
por: Lavalle, Carlo, et al.
Publicado: (2021)

Correction to: Structural and myocardial dysfunction in heart failure beyond ejection fraction
por: Severino, Paolo, et al.
Publicado: (2019)

Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy
por: Magnocavallo, Michele, et al.
Publicado: (2020)

Heart Failure Pharmacological Management: Gaps and Current Perspectives
por: Severino, Paolo, et al.
Publicado: (2023)

Predictors and Mortality for Worsening Left Ventricular Ejection Fraction in Patients With HFpEF
por: Chen, Liling, et al.
Publicado: (2022)

Worsening effect of testosterone deficiency on males with heart failure with preserved ejection fraction
por: Hamam, Ahmed, et al.
Publicado: (2022)

Clinical and Economic Burden of Chronic Heart Failure and Reduced Ejection Fraction Following a Worsening Heart Failure Event
por: Butler, Javed, et al.
Publicado: (2020)

Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial
por: Packer, Milton, et al.
Publicado: (2021)

Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction After a Recent Worsening Heart Failure Event
por: Carnicelli, Anthony P., et al.
Publicado: (2021)

Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event
por: Alsumali, Adnan, et al.
Publicado: (2021)

Reply to Weatherald et al.: Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Badagliacca, Roberto, et al.
Publicado: (2021)

Resource utilization and costs among patients with heart failure with reduced ejection fraction following a worsening heart failure event
por: Givertz, Michael M., et al.
Publicado: (2021)

Late gadolinium enhancement for re‐worsening left ventricular ejection fraction in patients with dilated cardiomyopathy
por: Nabeta, Takeru, et al.
Publicado: (2020)

Hemodynamic Evaluation of the Right Heart-Pulmonary Circulation Unit in Patients Candidate to Transjugular Intrahepatic Portosystemic Shunt
por: Manguso, Giulia, et al.
Publicado: (2022)

Vascular Calcification Progression Modulates the Risk Associated with Vascular Calcification Burden in Incident to Dialysis Patients
por: Bellasi, Antonio, et al.
Publicado: (2021)

Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat
por: González-Juanatey, José Ramón, et al.
Publicado: (2023)

The Worsening of Heart Failure with Reduced Ejection Fraction: The Impact of the Number of Hospital Admissions in a Cohort of Patients
por: Perea-Armijo, Jorge, et al.
Publicado: (2023)

Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial
por: Chatur, Safia, et al.
Publicado: (2023)

Myocardial Tissue Characterization in Heart Failure with Preserved Ejection Fraction: From Histopathology and Cardiac Magnetic Resonance Findings to Therapeutic Targets
por: Severino, Paolo, et al.
Publicado: (2021)

Comparison of Machine Learning Algorithms for Predicting Hospital Readmissions and Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction: Modeling Study
por: Ru, Boshu, et al.
Publicado: (2023)

Computational Simulator Models and Invasive Hemodynamic Monitoring as Tools for Precision Medicine in Pulmonary Arterial Hypertension
por: Manzi, Giovanna, et al.
Publicado: (2021)

Neutrophil‐to‐lymphocyte ratio and outcomes in patients with new‐onset or worsening heart failure with reduced and preserved ejection fraction
por: Curran, Fraser M., et al.
Publicado: (2021)

Exercise‐induced B‐lines in heart failure with preserved ejection fraction occur along with diastolic function worsening
por: Simonovic, Dejan, et al.
Publicado: (2021)

Predictive Value of Measures of Vascular Calcification Burden and Progression for Risk of Death in Incident to Dialysis Patients
por: Bellasi, Antonio, et al.
Publicado: (2021)

CARDIOSIM(©): The First Italian Software Platform for Simulation of the Cardiovascular System and Mechanical Circulatory and Ventilatory Support
por: De Lazzari, Beatrice, et al.
Publicado: (2022)

ECMO Assistance during Mechanical Ventilation: Effects Induced on Energetic and Haemodynamic Variables
por: De Lazzari, Beatrice, et al.
Publicado: (2021)

Complex connections: A young man presenting with shortness of breath, hypoxemia, right lumbar pain and left limb swelling
por: Filomena, Domenico, et al.
Publicado: (2022)

Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF
por: Docherty, Kieran F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6cnu5kqbia0bme4de9p8c8l0u3